Loft A G, Høgdall E, Larsen S O, Nørgaard-Pedersen B
Department of Clinical Biochemistry, Statens Seruminstitut, Copenhagen, Denmark.
Prenat Diagn. 1993 Feb;13(2):93-109. doi: 10.1002/pd.1970130204.
Amniotic fluid samples received for routine prenatal diagnosis of open neural tube defects were used for a study to compare amniotic fluid acetylcholinesterase (AChE) determination using a monoclonal antibody (4F19) enzyme antigen immunoassay and amniotic fluid alpha-fetoprotein (AFP) measurement as diagnostic tests for open neural tube defects. The study was based on 9964 women with singleton pregnancies and known outcome (including 6 with anencephaly and 18 with open spina bifida) having an amniocentesis at 14-23 weeks of gestation. The AChE immunoassay yielded detection rates for anencephaly of 100 per cent (95 per cent confidence interval (CI) 54.07-100 per cent), for open spina bifida of 100 per cent (95 per cent CI 81.47-100 per cent), for anterior abdominal wall defects of 20 per cent (95 per cent CI 0.51-71.64 per cent), and a false-positive rate of 0.22 per cent (95 per cent CI 0.14-0.34 per cent) excluding anencephaly, open spina bifida, and anterior abdominal wall defects. For similar detection rates the false-positive rate of the AFP test was significantly higher, 0.74 per cent (95 per cent CI 0.58-0.94 per cent). On the basis of these findings, it is recommended that the technically simple AChE immunoassay should be used on all samples; the AFP test should only be used on the 0.5 per cent of the samples with concentrations of AChE activity > or = 8.5 nkat/l for clear samples and blood-stained samples becoming clear after centrifugation, and > or = 25.0 nkat/l for blood-stained samples that are discoloured after centrifugation; an AFP cut-off level of 2.0 MOM is recommended for this policy. Thereby, the detection rates for anencephaly, open spina bifida, and anterior abdominal wall defects would be 100, 100, and 20 per cent, respectively (95 per cent CIs 54.07-100, 81.47-100, and 0.51-71.64 per cent, respectively), and the false-positive rate would be 0.08 per cent (95 per cent CI 0.03-0.16 per cent) (excluding anencephaly, open spina bifida, and anterior abdominal wall defects).
用于开放性神经管缺陷常规产前诊断的羊水样本被用于一项研究,以比较使用单克隆抗体(4F19)酶抗原免疫测定法测定羊水乙酰胆碱酯酶(AChE)和测量羊水甲胎蛋白(AFP)作为开放性神经管缺陷诊断试验的效果。该研究基于9964名单胎妊娠且结局已知的女性(包括6例无脑儿和18例开放性脊柱裂),她们在妊娠14至23周时接受了羊膜腔穿刺术。AChE免疫测定法对无脑儿的检出率为100%(95%置信区间(CI)54.07 - 100%),对开放性脊柱裂的检出率为100%(95%CI 81.47 - 100%),对前腹壁缺陷的检出率为20%(95%CI 0.51 - 71.64%),排除无脑儿、开放性脊柱裂和前腹壁缺陷后的假阳性率为0.22%(95%CI 0.14 - 0.34%)。对于类似的检出率,AFP检测的假阳性率显著更高,为0.74%(95%CI 0.58 - 0.94%)。基于这些发现,建议对所有样本采用技术上简单的AChE免疫测定法;AFP检测仅应用于0.5%的样本,对于清亮样本以及离心后变清亮的血性样本,AChE活性浓度≥8.5纳摩尔/升,对于离心后仍有颜色的血性样本,AChE活性浓度≥25.0纳摩尔/升;为此项策略建议AFP临界值水平为2.0倍中位数倍数(MOM)。由此,无脑儿、开放性脊柱裂和前腹壁缺陷的检出率将分别为100%、100%和20%(95%CI分别为54.07 - 100%、81.47 - 100%和0.51 - 71.64%),假阳性率将为0.08%(95%CI 0.03 - 0.16%)(排除无脑儿、开放性脊柱裂和前腹壁缺陷)。